During the past decade, Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan" #1 collaborator was "Celgene Corporation" with 1 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "The Leukemia and Lymphoma Society" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan" are "Acute Myeloid Leukemia" (1 trials), "Lymphoma, Follicular" (1 trials), "Malignant Haematological Disease" (1 trials), "Multiple Myeloma" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan" in a lesser frequency.

Most popular intervention types in "Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan" are "Drug" (3 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bone marrow sample" (1 trials), "CPX-351" (1 trials), "Intensive Salvage Therapy" (1 trials), "Pomalidomide" (1 trials) and "Reduced_intensity conditioning" (1 trials). Other intervention names were less common.

The vast majority of trials in "Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".